Cite

HARVARD Citation

    Fiorino, G. et al. (2017). Letter: immunogenicity of infliximab originator vs. CT‐P13 in IBD patients. Alimentary pharmacology & therapeutics. 46 (9), pp. 903-905. [Online]. 
  
Back to record